4//SEC Filing
Aliski William 4
Accession 0001062993-22-023027
CIK 0001273636other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:21 AM ET
Size
16.6 KB
Accession
0001062993-22-023027
Insider Transaction Report
Form 4
Aliski William
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−25,000→ 0 totalExercise: $4.40Exp: 2028-09-20→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $3.02Exp: 2029-12-04→ Common Stock (10,000 underlying) - Disposition from Tender
Common Stock
2022-11-30−8,500→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−10,000→ 0 totalExercise: $6.90Exp: 2028-11-15→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−12,000→ 0 totalExercise: $4.72Exp: 2030-12-16→ Common Stock (12,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−14,000→ 0 totalExercise: $2.17Exp: 2031-11-30→ Common Stock (14,000 underlying)
Footnotes (3)
- [F1]Includes 1,500 shares held by the Reporting Person's wife in a self-directed IRA.
- [F2]At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (1) $0.34 per share of common stock of the Issuer ("Common Stock"), without interest and less any applicable withholding taxes (the "Cash Consideration"); and (2) one contingent value right ("CVR") per share of Common Stock representing the right to receive potential milestone payments, currently estimated to be up to approximately $0.73 per CVR in the aggregate (without interest and less any applicable withholding taxes) (the Cash Consideration plus one CVR, collectively, as such amount may be increased in accordance with the terms of the Merger Agreement, the "Offer Price"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price.
- [F3]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.
Issuer
APPLIED GENETIC TECHNOLOGIES CORP
CIK 0001273636
Entity typeother
Related Parties
1- filerCIK 0001598426
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 9:21 AM ET
- Size
- 16.6 KB